United States · FDA National Drug Code directory
Oxcarbazepine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72888-087_4b920b8e-b260-b6a0-e063-6294a90a3490
- Product NDC
- 72888-087
- Form
- TABLET, FILM COATED
- Composition / generic term
- oxcarbazepine
- Labeler
- Advagen Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210319
- Source listing expiry
- 20271231
Source-listed ingredients
- OXCARBAZEPINE — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, FILM COATED in 1 BOTTLE (72888-087-01) · 72888-087-01
- 500 TABLET, FILM COATED in 1 BOTTLE (72888-087-05) · 72888-087-05
- 30 TABLET, FILM COATED in 1 BOTTLE (72888-087-30) · 72888-087-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →